Atezolizumab Shows Antitumor Activity in Renal Cell Carcinoma [Immunotherapy]

The anti–PD-L1 antibody atezolizumab is safe and active in patients with metastatic RCC.

from Cancer via ola Kala on Inoreader http://ift.tt/1M2dvFc
via IFTTT